AMAnna Mazanova

Anna Mazanova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anna Mazanova has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The impact of vitamin D(3) on bone remodeling in different types of experimental pathology

    by A. O. Mazanova, O. O. Makarova, A. V. Khomenko, V. M. Vasylevska, O. Yu. Lototska, I. O. Shymanskyi, M. M. Veliky

    Osteoporosis is a progressive systemic skeletal disease characterized by a decrease in bone density, impairment of its microarchitectonics, and an increased risk of fractures that occur under minimal or no mechanical stress. One of the main causes of osteoporosis is vitamin D deficiency, which leads to disruption of normal bone remodeling. The aim of our study was to analyze the features of the process of bone tissue remodeling by measuring the key biochemical markers of bone formation/resorption in primary and secondary osteoporosis, as well as to investigate the potential corrective effect of vitamin D3 supplementation. The work was conducted on rats with different osteoporosis models: alimentary, dysfunctional and secondary osteoporosis associated with diabetes mellitus. We used ELISA to measure 25(OH)D content in blood serum. Blood serum and bone tissue calcium, and alkaline phosphatase activity were determined with bioassay kits. The content of inorganic phosphate in blood serum and ash was assayed by the Dyce method. It was shown that all the studied pathological conditions were accompanied by vitamin D deficiency, which led to impaired absorption of calcium in the intestine and reabsorption of inorganic phosphates by the kidneys, reducing, as a result, their concentration in the blood serum. Hypocalcemia and hypophosphatemia contributed to the disruption of normal bone remodeling, excessive activation of alkaline phosphatase, and a decrease in the content of calcium and phosphate in bone tissue. Thus, sufficient vitamin D bioavailability was confirmed to be critical for effective bone remodeling in primary and secondary osteoporosis. Keywords: bone remodelin, osteoporosis, type 1 diabetes mellitus, vitamin D


  • The link between vitamin D status and NF-κB-associated renal dysfunction in experimental diabetes mellitus

    by Anna Mazanova, Ihor Shymanskyi, Olha Lisakovska, Dmytro Labudzynskyi, Anna Khomenko, Mykola Veliky


  • Open Access

    Роль вітамін D-авто-/паракринної системи в розвитку метаболічного запального процесу в тканині печінки за експериментального цукрового діабету 2-го типу

    by I.O. Shymanskyi, A.O. Mazanova, O.O. Lisakovska, D.O. Labudzynskyi, O.O. Makarova, Yu.I. Komisarenko, M.M. Veliky

    На сьогодні дефіцит вітаміну D3 (холекальциферолу) та порушення сигналювання через рецептор вітаміну D (vitamin D receptor, VDR) вважають одними із факторів ризику розвитку гепатопатії на тлі цукрового діабету 2-го типу (ЦД2). Протизапальна і гепатопротекторна дія вітаміну D3 і в цілому наукове обґрунтування можливості його ефективного застосування в клініці ЦД2 активно висвітлюється в літературі, однак конкретні механізми залишаються недостатньо з’ясованими. Мета — дослідження впливу вітаміну D3 на рівень експресії мРНК ключових компонентів вітамін D-авто-/паракринної системи та цитокінового шляху фактора некрозу пухлини-альфа/транскрипційного фактора NF-κB (tumor necrosis factor alpha/nuclear factor kappa-light-chainenhancer of activated B cells, TNF-α/NF-κB) у тканині печінки за експериментального ЦД2. Матеріал і методи.У щурів-самців лінії Вістар викликали ЦД2 шляхом поєднання високожирової дієти та низької дози стрептозотоцину (25 мг/кг). Вимірювання вмісту триацилгліцеролів, холестеролу, вищих жирних кислот, загальних ліпідів та загального холестеролу в сироватці крові проводили стандартними біохімічними методами. Вміст 25(OH)D визначали методом імуноензимного аналізу. Аналіз експресії мРНК генів RelA, Iκb, Tnf-α, Cyp27a1, Cyp2r1,Cyp27b1 та Vdr проводили методом полімеразної ланцюгової реакції (ПЛР) у реальному часі. Результати. Експериментальний ЦД2 супроводжувався дефіцитом вітаміну D в організмі піддослідних тварин та розвитком діабетичної гепатопатії, свідченням чого є підвищення активності аланінамінотрансферази, а також акумулювання холестеролу, триацилгліцеролів і вищих жирних кислот у крові тварин. Показано зниження вмісту мРНК ключових компонентів вітамін D-авто-/паракринної системи в печінці діабетичних тварин, що призводило допорушення сигналювання через VDR та активування цитокінового шляху TNF-α/NF-κB. Введення вітаміну D3 в дозі 800 МО/кг протягом 30 діб тваринам із ЦД2 істотно нормалізувало експресію Vdr та ензимів метаболічного перетворення вітаміну D у тканині печінки та знижувало експресію прозапальних факторів — NF-κB та TNF-α. Висновки. Застосування вітаміну D3 в комплексній терапії ЦД2 потенційно може чинити гепатопротекторний ефект шляхом нормалізування функціонального стану вітамін D-авто-/паракринної системи печінки та модулювання прозапальних процесів, залежних від ядерного фактора κВ.


  • Open Access

    Vitamin D Auto-/Paracrine System Is Involved in Modulation of Glucocorticoid-Induced Changes in Angiogenesis/Bone Remodeling Coupling

    by Olha Lisakovska, Ihor Shymanskyi, Dmytro Labudzynskyi, Anna Mazanova, Mykola Veliky

    Osteoporosis is a devastating side effect of chronic glucocorticoid (GC) treatment. Despite the crucial role of vitamin D (VD) in bone homeostasis, the precise molecular mechanisms of its action on GC-induced disturbances of bone remodeling remain undefined. The study was performed to elucidate the relation of VD status to GC-induced changes of the angiogenesis/osteogenesis/bone resorption coupling in bone tissue. Female Wistar rats received prednisolone (5 mg/kg of b.w.) with or without VD3 (1000 IU/kg of b.w., for 30 days). Biomechanical parameters of rat femurs were assessed by the three-point bending test. The levels of calcium, inorganic phosphate, activity of total alkaline phosphatase (ALP), and its isoenzymes were determined spectrophotometrically. Vascular endothelial growth factor-A (VEGF-A) and caspase-3 protein levels were detected by western blotting. Vdr and Cyp27b1 mRNAs were measured by qRT-PCR. Receptor activator of nuclear factor κB (RANK) expression in bone sections was visualized immunohistochemically. Serum 25(OH)D was assayed by ELISA. GC administration led to a decrease in maximal load (by 1.2-fold) and stiffness and toughness (by 1.3-fold), which was accompanied by a 3-fold reduction of 25(OH)D level, an elevation of the ALP bone isoenzyme activity in serum, hypocalcaemia, and hypophosphatemia. Along with prednisolone-induced VD deficiency, an impaired synthesis of Vdr (−30%) and Cyp27b1 (+71%) mRNA was observed, reflecting deregulation of bone tissue VD-auto-/paracrine system. GC caused an increase in caspase-3 content, suppressed the synthesis of the osteoclastic marker RANK, and altered angiogenesis/osteogenesis coupling by significantly reducing the level of VEGF-A.VD3 treatment restored serum 25(OH)D content and the expression of key components of the VD-auto-/paracrine system. VD3 supplementation diminished cell apoptosis and strongly improved angiogenesis/osteogenesis coupling as well as mineral metabolism and biomechanical parameters of femurs in GC-administered rats. Thus, VD3 can have a beneficial effect on the correction of GC-induced pathological changes in bone remodeling.


  • Open Access

    Effects of Cholecalciferol on Key Components of Vitamin D-Endo/Para/Autocrine System in Experimental Type 1 Diabetes

    by Anna Mazanova, Ihor Shymanskyi, Olha Lisakovska, Lala Hajiyeva, Yulia Komisarenko, Mykola Veliky

    Objectives.Recent prospective studies have found the associations between type 1 diabetes (T1D) and vitamin D deficiency. We investigated the role of vitamin D in the regulation of 25OHD-1α-hydroxylase (CYP27B1) and VDR expression in different tissues of T1D rats.Design.T1D was induced in male Wistar rats by streptozotocin (55 mg/k b.w.). After 2 weeks of T1D, the animals were treated orally with or without vitamin D3(cholecalciferol; 100 IU/rat, 30 days).Methods.Serum 25-hydroxyvitamin D (25OHD) was detected by ELISA. CYP27A1, CYP2R1, CYP27B1, and VDR were assayed by RT-qPCR and Western blotting or visualized by immunofluorescence staining.Results.We demonstrated that T1D led to a decrease in blood 25OHD, which is probably due to the established downregulation of CYP27A1 and CYP2R1 expression. Vitamin D deficiency was accompanied by elevated synthesis of renal CYP27B1 and VDR. Conversely, CYP27B1 and VDR expression decreased in the liver, bone tissue, and bone marrow. Cholecalciferol administration countered the impairments of the vitamin D-endo/para/autocrine system in the kidneys and extrarenal tissues of diabetic rats.Conclusions.T1D-induced vitamin D deficiency is associated with impairments of renal and extrarenal CYP27B1 and VDR expression. Cholecalciferol can be effective in the amelioration of diabetes-associated abnormalities in the vitamin D-endo/para/autocrine system.


  • Vitamin D3 protects against prednisolone-induced liver injury associated with the impairment of the hepatic NF-κB/iNOS/NO pathway

    by Olha Lisakovska, Ihor Shymanskyy, Anna Mazanova, Anna Khomenko, Mykola Veliky

    The study was carried out to define whether prednisolone-induced damage to hepatic cells is accompanied by excessive nitric oxide (NO) levels associated with nuclear factor kappa B (NF-κB)/inducible NO synthase (iNOS) activation and evaluate the efficacy of the treatment with vitamin D3. Histopathological examination, activities of liver transaminases (alanine aminotransferase and aspartate aminotransferase), and cell death assays consistently showed that prednisolone (5 mg/kg body weight, 30 days) induces chronic liver injury in female Wistar rats. Specifically, increased hepatocellular necrosis and caspase-3-dependent apoptosis were observed. Prednisolone enhanced iNOS protein expression, NO generation, and tyrosine nitration in liver cells. Despite unchanged hepatic level of the NF-κB/p65 protein, prednisolone increased inhibitory κB-α (IκB-α) degradation, nuclear translocation, and phosphorylation of NF-κB/p65 at Ser311, indicating that NF-κB activation can be involved in the induction of iNOS/NO. All changes were associated with a 2.9-fold decrease in the serum content of 25-hydroxyvitamin D3 and significant reduction of hepatic vitamin D3 receptor (VDR) expression that points reliably to vitamin D3 deficiency and failures in VDR signaling. Vitamin D3 co-administration (100 IU/rat, 30 days) prevented glucocorticoid-evoked abnormalities in hepatic tissue. In conclusion, prednisolone-induced liver disturbances were associated with the impairment of NF-κB/iNOS/NO responses that can be ameliorated by vitamin D3 treatment through VDR-mediated mechanisms.


  • Open Access

    Prednisolone and vitamin D(3) modulate oxidative metabolism and cell death pathways in blood and bone marrow mononuclear cells

    by I. O. Shymanskyy, O. O. Lisakovska, A. O. Mazanova, D. O. Labudzynskyi, A. V. Khomenko, M. M. Veliky

    The study was designed to evaluate reactive oxygen species (ROS)/nitric oxide (NO) formation and apoptotic/necrotic cell death elicited by prednisolone in peripheral blood and bone marrow mononuclear cells and to define the efficacy of vitamin D3 to counter glucocorticoid (GC)-induced changes. It was shown that prednisolone (5 mg per kg of female Wistar rat’s body weight for 30 days) evoked ROS and NO overproduction by blood mononuclear cells (monocytes and lymphocytes) that correlated with increased cell apoptosis and necrosis. In contrast, prednisolone did not affect ROS/NO levels in bone marrow mononuclear cells that corresponded to lower level of cell death than in the control. Alterations of prooxidant processes revealed in mononuclear cells and associated with GC action were accompanied by vitamin D3 deficiency in animals, which was assessed by the decreased level of blood serum 25-hydroxivitamin D3 (25OHD3). Vitamin D3 administration (100 IU per rat daily for 30 days, concurrently with prednisolone administration) completely restored 25OHD3 content to the control values and significantly reversed ROS and NO formation in blood mononuclear cells, thus leading to decreased apoptosis. In bone marrow, vitamin D3 activated ROS/NO production and protein nitration that may play a role in prevention of prednisolone-elicited increase in bone resorption. We conclude that vitamin D3 shows a profound protection against GC-associated cellular damage through regulating intracellular ROS/NO formation and cell death pathways.


    • 1 April 2016
      • Vol. 20  (7) , 1379-83

    Effects of vitamin D3 and vitamin E on prednisolone-induced alterations of phagocyte function.

    by I O Shymanskyy, Olha Lisakovska, A O Mazanova, V M Riasniy, Mykola Veliky

    To evaluate the effectiveness of vitamin D3 and its combined action with vitamin E in the correction of the impairments of phagocyte function caused by chronic glucocorticoid administration. Phagocytic activity was assessed by the ability of peripheral blood neutrophils and monocytes to capture FITC-labeled Escherichia coli using flow cytometry. Metabolic activity of neutrophils was measured cytochemically as nitro blue tetrazolium (NBT) reduction test. Intracellular reactive oxygen species (ROS) were detected by 2',7'-dichlorofluorescein fluorescence. Prednisolone administration (5 mg/kg b.w., 30 days) was accompanied by vitamin D3 deficiency and decompensation of phagocyte function associated with antimicrobial activity (decrease in NBT reduction rate, ROS formation and phagocytic activity). Vitamin D3 co-administration with prednisolone and, to a greater extent, its combination with α-tocopherol (100 IU and 0.5 mg/rat, 30 days respectively) partially restored phagocyte function. These data suggest that vitamin D3 and α-tocopherol can prevent immunosuppressive effects of prednisolone through elevating the efficacy of oxygen-dependent mechanisms of phagocytosis and increasing the functional activity of phagocytic cells.